Skip to main content Back to Top
Advertisement

12/23/2020

Ceftazidime Injection

Products Affected - Description

    • Tazicef powder for solution for injection, Pfizer, 2 gram, vial, 10 count, NDC 00409-5084-11

Reason for the Shortage

    • Pfizer has Tazicef on shortage due to increased demand.
    • Sagent has ceftazidime injection available.
    • BBraun had ceftazidime on allocation due to increased demand.
    • Teligent has Fortaz available.
    • WG Critical Care has ceftazidime available.

Available Products

    • Fortaz powder for solution for injection, Teligent, 1 gram, vial, 10 count, NDC 24987-0378-10
    • Fortaz powder for solution for injection, Teligent, 500 mg, vial, 10 count, NDC 24987-0377-10
    • Tazicef powder for solution for injection, Pfizer, 1 gram, ADD-Vantage vial, 25 count, NDC 00409-5092-16
    • Tazicef powder for solution for injection, Pfizer, 1 gram, vial, 25 count, NDC 00409-5082-16
    • Tazicef powder for solution for injection, Pfizer, 2 gram, ADD-Vantage vial, 10 count, NDC 00409-5093-11
    • Tazicef powder for solution for injection, Pfizer, 6 gram, vial, 6 count, NDC 00409-5086-11
    • Ceftazidime injection, BBraun, 1 gram/50 mL, premixed bag, 24 count, NDC 00264-3143-11
    • Ceftazidime injection, BBraun, 2 gram/50 mL, premixed bag, 24 count, NDC 00264-3145-11
    • Ceftazidime powder for solution for injection, Sagent, 1 gram, vial, 25 count, NDC 25021-0127-20
    • Ceftazidime powder for solution for injection, Sagent, 2 gram, vial, 10 count, NDC 25021-0128-50
    • Ceftazidime powder for solution for injection, Sagent, 6 gram, vial, 6 count, NDC 25021-0129-99
    • Ceftazidime powder for solution for injection, WG Critical Care, 1 gram, vial, 25 count, NDC 44567-0235-25
    • Ceftazidime powder for solution for injection, WG Critical Care, 2 gram, vial, 10 count, NDC 44567-0236-10
    • Ceftazidime powder for solution for injection, WG Critical Care, 6 gram, vial, 6 count, NDC 44567-0237-06

Estimated Resupply Dates

    • Pfizer has Tazicef 2 gram vials available in limited supply.

Updated

Updated December 23, 2020 by Michelle Wheeler, PharmD, Drug Information Specialist. Created November 29, 2011 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2020, Drug Information Service, University of Utah, Salt Lake City, UT.

ADVERTISEMENT

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins


ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.